Talk:Main Page: Difference between revisions
Jump to navigation
Jump to search
Research Updates
[+] All Pages
[+] Recent Changes
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<div style="display: inline-block; width:100%;"> | <div style="display: inline-block; width:100%;"> | ||
{{Bubble | {{Bubble | ||
| h-color=#3AD769 | | h-color=#3AD769 | ||
Revision as of 04:46, 24 September 2022
Research Updates
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.
A comparison between the ability of cyproterone acetate and spironolactone to lower testosterone levels. Although it shows that cyproterone has a greater effect towards lowering testosterone levels, it ironically notes this metric isn't very meaningful since spironolactone is only an antagonist and does not inhibit steroidogenesis.
The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them, or find more research.
It is at the heart of all our goals stated in the "About Us" tab below, and one of the more polished articles on the wiki having been curated by our research librarian LilianaUmbra.
[+] All Pages
[+] Recent Changes
No changes during the given period match these criteria.